Page 1 of 1

To keep up with the latest entrepreneurial

Posted: Wed Jan 08, 2025 3:54 am
by prisilabr88
Use intestinal bacteria to activate the immune response in the body. This will increase the possibility of attacking cancer cells and increase the therapeutic effect of cancer patients. Zhiming, CEO of Chengjiao Biotechnology, also shared with us, This idea also comes from past experience in the research and development of new cancer drugs and foreign trends. Many foreign biotechnology companies have established research topics related to intestinal bacteria. , although the progress is very early, major international pharmaceutical companies have completed many licensing cooperation cases, and around 2018, the licensing funds have reached 5 to 6 billion US dollars.

Year, the U.S. FDA approved two fecal bacteria drugs, confirming that germany telegram number feces can be regarded as a complex but effective therapeutic material. Chengjiao Biotech also saw opportunities for intestinal bacteria to treat diseases. Subscribe for free to the Meet Innovation and Entrepreneurship enewsletter news and community dynamics Please enter Email Our team has been engaged in the development of new cancerrelated drugs for a long time. In the current situation, the effectiveness of treatment for cancer patients is not high at this stage. The therapeutic effectiveness of any new drug is usually only.

This means that there is always a shortage of new cancer drugs. , is an unsatisfied medical market. In addition, the treatment process is actually very laborious and even undignified. Chengjiao Biotechnology hopes to improve immunity by regulating the intestinal flora of the digestive tract, so that cancer patients or ordinary people can improve their immunity. Good health can be maintained, and it can even allow cancer patients to have more dignity and maintain a good quality of life during treatment. This is what we want to do most. null Chengjiao Biotech used experimental experience and technology to find.